Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 7/20 | 0.35 |
| ▸ | LMNA | P02545 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GYS1 | P13807 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30772116 | 0.90 | ESR1 (0.44) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL30772115 | 0.90 | ESR1 (0.44) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL3696821 | 0.90 | ESR1 (0.44) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL12714322 | 0.85 | ESR1 (0.41) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL19792259 | 0.76 | FGFR1 (0.41) | ESR1ESR2TP53TDP1 | |
| SCHEMBL22110104 | 0.76 | MAPT (0.36) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL12714325 | 0.75 | MAPT (0.37) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL11802995 | 0.75 | ESR1 (0.46) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL13030469 | 0.74 | MAPT (0.38) | ESR1ESR2KMT2AMAPTLMNA | |
| SCHEMBL7059048 | 0.73 | ALDH1A1 (0.42) | ESR1ESR2KMT2ALMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3348549-B1 | METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS(2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)-1,3,5- TRIAZINE COMPOUND AND 2,4,6-TRIS(2,4-DIHYDROXY-3-METHYLPHENYL)-1,3,5-TRIAZINE | KANEKA CORP (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-10351538-B2 | Methods respectively for producing 2,4,6-tris (2-hydroxy-3-methyl-4-alkoxyphenyl)-1,3,5-triazine compound and 2,4,6-tris(2,4-dihydroxy-3-methylphenyl)-1,3,5-triazine | KANEKA CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-10351538-B2 | Methods respectively for producing 2,4,6-tris (2-hydroxy-3-methyl-4-alkoxyphenyl)-1,3,5-triazine compound and 2,4,6-tris(2,4-dihydroxy-3-methylphenyl)-1,3,5-triazine | KANEKA CORPORATION (JP) | 2019-07-16 | — | — | US | disclosed |
| US-20180305325-A1 | METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS (2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)- 1,3,5- TRIAZINE COMPOUND AND 2,4,6-TRIS(2,4-DIHYDROXY-3-METHYLPHENYL)-1,3,5-TRIAZINE | KANEKA CORPORATION (JP) | 2018-10-25 | — | — | US | disclosed |
| EP-3348549-A1 | METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS(2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)-1,3,5- TRIAZINE COMPOUND AND 2,4,6-TRIS(2,4-DIHYDROXY-3-METHYLPHENYL)-1,3,5-TRIAZINE | Kaneka Corporation (JP) | 2018-07-18 | — | — | EP | disclosed |
| WO-2017043416-A1 | METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS(2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)-1,3,5- TRIAZINE COMPOUND AND 2,4,6-TRIS(2,4-DIHYDROXY-3-METHYLPHENYL)-1,3,5-TRIAZINE | 株式会社カネカ | 2017-03-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305325-A1 | METHODS RESPECTIVELY FOR PRODUCING 2,4,6-TRIS (2-HYDROXY-3-METHYL-4-ALKOXYPHENYL)- 1,3,5- TRIAZINE COMPOUND AND 2,4,6-TRIS(2,4-DIHYDROXY-3-METHYLPHENYL)-1,3,5-TRIAZINE | ALKBH2, ALKBH5, TET3 | ESR1 4033/4885ESR2 2881/4885KMT2A 146/4885 |
| US-10351538-B2 | Methods respectively for producing 2,4,6-tris (2-hydroxy-3-methyl-4-alkoxyphenyl)-1,3,5-triazine compound and 2,4,6-tris(2,4-dihydroxy-3-methylphenyl)-1,3,5-triazine | ALKBH2, ALKBH5, TET3 | ESR1 4033/4885ESR2 2881/4885KMT2A 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.